KL and clear cell adenocarcinoma: 2011). As KL was differentially expressed in our dataset (fold change TU/NO ‐3.43, P‐value 2.15E‐07), we tested the effect on patient survival on 468 samples of the TCGA clear cell carcinoma dataset implemented (Material and Methods). In accordance with the literature, lower expression levels of KL indicated lower patient survival (Risk Group Hazard Ratio 3.61, P‐value 4.41E‐14), as shown in Figure 8E–F.